To include your compound in the COVID-19 Resource Center, submit it here.

Melacine melanoma vaccine: Will begin this year a Phase III trial in 300 patients, comparing the agent given with interferon alfa-2b to interferon alone. End po

Ribi ImmunoChem Research Inc. (RIBI), Hamilton, Mont.
Product:

Read the full 83 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE